Download full press release.

Phasefocus contact:
Tracey Zimmermann,
+44(0)114 286 6377
Media contact:
Jezz Leckenby, +44(0)7843 012997
The Francis Crick Institute selects the Phasefocus Livecyte label-free cell
analysis system for their Light Microscopy facility.
Sheffield, UK, 13th June, 2017: Phasefocus provides a range of products and services based on its
proprietary Ptychographic Quantitative Phase Imaging (QPI) technology to provide a wide range
of analytical applications including label-free cell imaging and quantitative electron phase
microscopy. Here, they report on the Light Microscopy Science Technology Platform at the
Francis Crick Institute’s selection of the Livecyte label-free cell analysis system.
Dr Kurt Anderson heads up the Light Microscopy Science Technology Platform at the Francis Crick
Institute. They specialise in high resolution, high throughput, fluorescence microscopy, three
dimensional (3D) digital imaging, time-lapse and low-light-level imaging. The facility allows
access to state-of-the-art equipment including single and multiphoton laser scanning confocals,
spinning disc confocal, lightsheet and wide-field microscopes with deconvolution.
Dr Anderson leads a team in the development of light microscopy techniques and their
applications in collaborative projects with several Crick research laboratories. These include the
development of specialised imaging techniques, technology and data analysis. Live cell imaging is
one of the areas of particular emphasis. With this in mind along with the aim to keep the facility
up to date with the cutting-age imaging techniques, Dr Anderson has recently invested in the
Livecyte label-free cell analysis from Phasefocus.
Describing his decision and expectations for
the system, Dr Anderson said “Research at the forefront is highly competitive, and our scientists
are constantly on the lookout for something that will give them an edge. We were attracted to
the Livecyte by the unique combination of innovative optics and powerful image analysis
software.”
Dr Martin Humphry, CEO Phasefocus, commented “I’m delighted that the prestigious Francis
Crick Institute has chosen Phasefocus to supply a Livecyte cell analysis system to be one of the
first new instruments to be installed at their landmark new facility. We are looking forward to
working with the scientists at the Institute and I’m excited about the potential of the Livecyte
system for deepening understanding of the behaviour of live cells.”
Phasefocus sees the immense potential for the Livecyte technique and the wealth of information
available to be unlocked. Livecyte enables quantitative label-free live cell analysis. With robust
automatic tracking and behavioural analysis of hundreds of individual cells within heterogeneous
cell populations, it is now possible to image without the need for intrusive dyes or labels. Unique
morphological, temporal, and dynamic phenotypic data make it simple to gain new biological
insights and accelerate research.
For more information on ptychography and the Phasefocus Livecyte label-free kinetic cytometry
system, please visit the Phasefocus web site: www.phasefocus.com/livecyte/.
Attachment:
Phasefocus’ Livecyte Cell Analysis System
at the Francis Crick Institute (© FTI Consulting)
About Phasefocus:
Phasefocus brings to multiple markets a range of products and services based on its proprietary
Ptychographic Quantitative Phase Imaging (QPI) technology to provide a wide range of analytical
applications including label-free cell imaging and analysis and quantitative electron phase
microscopy.
Phasefocus’ label-free cell imaging and analysis tools offer researchers a revolutionary new ways
to study cell morphology and dynamic behaviour at the individual cell level.
They enable
individual cells to be tracked, label-free, for hours and days with unprecedented robustness and
accuracy.
About the Francis Crick Institute
The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the
fundamental biology underlying health and disease. Its work is helping to understand why
disease develops and to translate discoveries into new ways to prevent, diagnose and treat
illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.
For further information:
Please contact Phasefocus direct or their marketing agency, Talking Science:
Phase Focus Limited
Electric Works
Sheffield Digital Campus
Sheffield, S1 2BJ, UK
T +44(0)114 286 6377
M +44(0)7776 137841
www.phasefocus.com
[email protected]
Talking Science Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA, UK
T +44(0)1799 521881
M +44(0)7843 012997
www.talking-science.com
[email protected]